Efficacy and Safety of Adalimumab Long-Term Administration with Immunosuppressants at Juvenile Idiopathic Arthritis without Systemic Manifestations

• Автори: E. I. Alexeeva (Автор), T. M. Bzarova (Автор), S. I. Valieva (Автор), R. V. Denisova (Автор), K. B. Isaeva (Автор), E. G. Chistyakova (Автор), A. M. Chomakhidze (Автор), T. V. Sleptsova (Автор), N. I. Taibulatov (Автор), A. N. Fetisova (Автор), M. Sh. Shingarova (Автор)
• Формат: Книга
• Опубліковано: "Paediatrician" Publishers LLC, 2015-09-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Background: Treatment of patients with juvenile idiopathic arthritis (JIA) is one of the most complex and urgent problems of rheumatology.Objective: Our aim was to evaluate the efficacy and safety of adalimumab therapy combined with immunosuppressants in patients with JIA without systemic manifestat...